Category: Corporate NewsBy adminApril 1, 2020 Author: admin https://ramedapharma-ir.com Post navigationPreviousPrevious post:EGX disclosure announcing the acquisition of a generic anti-inflammatory analgesic moleculeNextNext post:EGX Disclosure on BOD and shareholding structureRelated PostsRameda Initiates First Acquisition of 2025July 7, 2025Record Dividend Distribution DisclosureJuly 7, 2025Rameda One-Pager 1Q25May 13, 2025Earnings Release One-Pager 4Q24March 10, 2025Earning Release One Pager 3Q24November 14, 2024Rameda Completes Largest Acquisition to DateSeptember 30, 2024